Deutsche Forschungsgemeinschaft, Grant/Award Number: SFB636; Horizon 2020 Framework Programme, Grant/Award Number: 668863-SyBil-AA; ERA-Net NEURON program, Grant/Award Number: FKZ 01EW1112-TRANSALC; European Union's Horizon 2020 research and innovation program, Grant/Award Number: 668863-SyBil-AA S Mann, K., & Ackermann, K. (2000). Die OCDS-G: Psychometrische Kennwerte der deutschen Version der Obsessive Compulsive Drinking Scale. SUCHT, 46(2), 90-100. doi:10.1024/suc.2000.46.2.90 Loeber, S., Kiefer, F., Wagner, F., Mann, K., & Croissant, B. (2009). Behandlungserfolg nach qualifiziertem Alkoholentzug. Der Nervenarzt, 80(9), 1085-1092. doi:10.1007/s00115-009-2724-2

[EN] During the first weeks of abstinence, alcohol craving in patients may increase or "incubate." We hypothesize that Naltrexone (NTX) blocks this incubation effect. Here, we compared NTX effects on neural alcohol cue reactivity (CR) over the first weeks of abstinence and on long-term clinical outcomes to standard treatment. Male alcohol-dependent patients (n = 55) and healthy controls (n = 35) were enrolled. Participants underwent baseline psychometric testing and functional magnetic resonance imaging (fMRI) assessment of mesolimbic alcohol CR. Patients participated in a standard treatment program with the option of adjuvant NTX. They received another scan after 2 weeks of treatment. We found higher CR in several brain regions in patients versus healthy controls. CR significantly increased over 2 weeks in the standard treatment group (n = 13) but not in the NTX group (n = 22). NTX significantly attenuated CR in the left putamen and reduced relapse risk to heavy drinking within 3 months of treatment. Additionally, increased CR in the left putamen and its course over time predicted both NTX response and relapse risk. Carrier status for the functional OPRM1 variant rs1799971:A > G was considered but had no effect on NTX efficacy. In conclusion, NTX was most effective in patients with high CR in the left putamen. While the results from our naturalistic study await further confirmation from prospective randomized trials, they support a potential role of neural CR as a biomarker in the development of precision medicine approaches with NTX. Bach, P.; Weil, G.; Pompili, E.; Hoffmann, S.; Hermann, D.; Vollstädt-Klein, S.; Mann, K.... (2020). Incubation of neural alcohol cue reactivity after withdrawal and its blockade by naltrexone. Addiction Biology. 25(1):1-11. https://doi.org/10.1111/adb.12717 World Health Organization(2018)Global Status Report on Alcohol and Health. JonasDE AmickHR FeltnerC BobashevG ThomasK WinesR KimMM ShanahanE GassCE RoweCJ GarbuttJC(2014)In: Pharmacotherapy for Adults With Alcohol‐Use Disorders in Outpatient Settings: Rockville (MD). Heilig, M., Sommer, W. H., & Spanagel, R. (2015). The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research. Current Topics in Behavioral Neurosciences, 151-171. doi:10.1007/7854_2015_5006 Mann, K., Roos, C. R., Hoffmann, S., Nakovics, H., Leménager, T., Heinz, A., & Witkiewitz, K. (2017). Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes. Neuropsychopharmacology, 43(4), 891-899. doi:10.1038/npp.2017.282 Hendershot, C. S., Wardell, J. D., Samokhvalov, A. V., & Rehm, J. (2016). Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies. Addiction Biology, 22(6), 1515-1527. doi:10.1111/adb.12425 Schacht, J. P., Anton, R. F., Voronin, K. E., Randall, P. K., Li, X., Henderson, S., & Myrick, H. (2012). Interacting Effects of Naltrexone and OPRM1 and DAT1 Variation on the Neural Response to Alcohol Cues. Neuropsychopharmacology, 38(3), 414-422. doi:10.1038/npp.2012.195 Vollstädt-Klein, S., Loeber, S., Richter, A., Kirsch, M., Bach, P., von der Goltz, C., … Kiefer, F. (2011). Validating incentive salience with functional magnetic resonance imaging: association between mesolimbic cue reactivity and attentional bias in alcohol-dependent patients. Addiction Biology, 17(4), 807-816. doi:10.1111/j.1369-1600.2011.00352.x Yalachkov, Y., Kaiser, J., & Naumer, M. J. (2012). Functional neuroimaging studies in addiction: Multisensory drug stimuli and neural cue reactivity. Neuroscience & Biobehavioral Reviews, 36(2), 825-835. doi:10.1016/j.neubiorev.2011.12.004 Mann, K., Vollstädt‐Klein, S., Reinhard, I., Leménager, T., Fauth‐Bühler, M., Hermann, D., … Smolka, M. N. (2014). Predicting Naltrexone Response in Alcohol‐Dependent Patients: The Contribution of Functional Magnetic Resonance Imaging. Alcoholism: Clinical and Experimental Research, 38(11), 2754-2762. doi:10.1111/acer.12546 Reinhard, I., Leménager, T., Fauth-Bühler, M., Hermann, D., Hoffmann, S., Heinz, A., … Vollstädt-Klein, S. (2015). A comparison of region-of-interest measures for extracting whole brain data using survival analysis in alcoholism as an example. Journal of Neuroscience Methods, 242, 58-64. doi:10.1016/j.jneumeth.2015.01.001 Schacht, J. P., Anton, R. F., & Myrick, H. (2012). Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addiction Biology, 18(1), 121-133. doi:10.1111/j.1369-1600.2012.00464.x Schacht, J. P., Randall, P. K., Latham, P. K., Voronin, K. E., Book, S. W., Myrick, H., & Anton, R. F. (2017). Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology, 42(13), 2640-2653. doi:10.1038/npp.2017.74 Lukas, S. E., Lowen, S. B., Lindsey, K. P., Conn, N., Tartarini, W., Rodolico, J., … Penetar, D. M. (2013). Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: A bold FMRI study. NeuroImage, 78, 176-185. doi:10.1016/j.neuroimage.2013.03.055 Grimm, J. W., Hope, B. T., Wise, R. A., & Shaham, Y. (2001). Incubation of cocaine craving after withdrawal. Nature, 412(6843), 141-142. doi:10.1038/35084134 Pickens, C. L., Airavaara, M., Theberge, F., Fanous, S., Hope, B. T., & Shaham, Y. (2011). Neurobiology of the incubation of drug craving. Trends in Neurosciences, 34(8), 411-420. doi:10.1016/j.tins.2011.06.001 BIENKOWSKI, P. (2004). Time-dependent changes in alcohol-seeking behaviour during abstinence. European Neuropsychopharmacology, 14(5), 355-360. doi:10.1016/j.euroneuro.2003.10.005 Li, P., Wu, P., Xin, X., Fan, Y.-L., Wang, G.-B., Wang, F., … Lu, L. (2014). Incubation of alcohol craving during abstinence in patients with alcohol dependence. Addiction Biology, 20(3), 513-522. doi:10.1111/adb.12140 Dong, Y., Taylor, J. R., Wolf, M. E., & Shaham, Y. (2017). Circuit and Synaptic Plasticity Mechanisms of Drug Relapse. The Journal of Neuroscience, 37(45), 10867-10876. doi:10.1523/jneurosci.1821-17.2017 Luís, C., Cannella, N., Spanagel, R., & Köhr, G. (2017). Persistent strengthening of the prefrontal cortex – nucleus accumbens pathway during incubation of cocaine-seeking behavior. Neurobiology of Learning and Memory, 138, 281-290. doi:10.1016/j.nlm.2016.10.003 BECK, A. T. (1961). An Inventory for Measuring Depression. Archives of General Psychiatry, 4(6), 561. doi:10.1001/archpsyc.1961.01710120031004 Fagerstrom, K.-O., & Schneider, N. G. (1989). Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire. Journal of Behavioral Medicine, 12(2), 159-182. doi:10.1007/bf00846549 Kivlahan, D. R., Sher, K. J., & Donovan, D. M. (1989). The Alcohol Dependence Scale: a validation study among inpatient alcoholics. Journal of Studies on Alcohol, 50(2), 170-175. doi:10.15288/jsa.1989.50.170 SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction, 88(6), 791-804. doi:10.1111/j.1360-0443.1993.tb02093.x SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989). Assessment of Alcohol Withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Addiction, 84(11), 1353-1357. doi:10.1111/j.1360-0443.1989.tb00737.x Tonigan, J. S., Miller, W. R., & Brown, J. M. (1997). The reliability of Form 90: an instrument for assessing alcohol treatment outcome. Journal of Studies on Alcohol, 58(4), 358-364. doi:10.15288/jsa.1997.58.358 Bach, P., Vollsta¨dt-Klein, S., Kirsch, M., Hoffmann, S., Jorde, A., Frank, J., … Kiefer, F. (2015). Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome: A functional imaging study in alcohol dependent subjects. European Neuropsychopharmacology, 25(8), 1128-1135. doi:10.1016/j.euroneuro.2015.04.013 Jorde, A., Bach, P., Witt, S. H., Becker, K., Reinhard, I., Vollstädt-Klein, S., … Kiefer, F. (2014). Genetic Variation in the Atrial Natriuretic Peptide Transcription Factor GATA4 Modulates Amygdala Responsiveness in Alcohol Dependence. Biological Psychiatry, 75(10), 790-797. doi:10.1016/j.biopsych.2013.10.020 Kiefer, F., Witt, S. H., Frank, J., Richter, A., Treutlein, J., Lemenager, T., … Mann, K. (2010). Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate. The Pharmacogenomics Journal, 11(5), 368-374. doi:10.1038/tpj.2010.51 Anton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008). An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence. Archives of General Psychiatry, 65(2), 135. doi:10.1001/archpsyc.65.2.135 Chamorro, A.-J., Marcos, M., Mirón-Canelo, J.-A., Pastor, I., González-Sarmiento, R., & Laso, F.-J. (2012). Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis. Addiction Biology, 17(3), 505-512. doi:10.1111/j.1369-1600.2012.00442.x Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O’Brien, C. P. (2003). A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients. Neuropsychopharmacology, 28(8), 1546-1552. doi:10.1038/sj.npp.1300219 Ramchandani, V. A., Umhau, J., Pavon, F. J., Ruiz-Velasco, V., Margas, W., Sun, H., … Heilig, M. (2010). A genetic determinant of the striatal dopamine response to alcohol in men. Molecular Psychiatry, 16(8), 809-817. doi:10.1038/mp.2010.56 Bennett, C. M., Wolford, G. L., & Miller, M. B. (2009). The principled control of false positives in neuroimaging. Social Cognitive and Affective Neuroscience, 4(4), 417-422. doi:10.1093/scan/nsp053 Noori, H. R., Cosa Linan, A., & Spanagel, R. (2016). Largely overlapping neuronal substrates of reactivity to drug, gambling, food and sexual cues: A comprehensive meta-analysis. European Neuropsychopharmacology, 26(9), 1419-1430. doi:10.1016/j.euroneuro.2016.06.013 Sjoerds, Z., de Wit, S., van den Brink, W., Robbins, T. W., Beekman, A. T. F., Penninx, B. W. J. H., & Veltman, D. J. (2013). Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients. Translational Psychiatry, 3(12), e337-e337. doi:10.1038/tp.2013.107 Altman, D. G., & Andersen, P. K. (1999). Calculating the number needed to treat for trials where the outcome is time to an event. BMJ, 319(7223), 1492-1495. doi:10.1136/bmj.319.7223.1492 Vollstädt-Klein, S., Loeber, S., Kirsch, M., Bach, P., Richter, A., Bühler, M., … Kiefer, F. (2011). Effects of Cue-Exposure Treatment on Neural Cue Reactivity in Alcohol Dependence: A Randomized Trial. Biological Psychiatry, 69(11), 1060-1066. doi:10.1016/j.biopsych.2010.12.016 Koob, G. F., & Moal, M. L. (1997). Drug Abuse: Hedonic Homeostatic Dysregulation. Science, 278(5335), 52-58. doi:10.1126/science.278.5335.52 Bujarski, S., & Ray, L. A. (2014). Subjective response to alcohol and associated craving in heavy drinkers vs. alcohol dependents: An examination of Koob’s allostatic model in humans. Drug and Alcohol Dependence, 140, 161-167. doi:10.1016/j.drugalcdep.2014.04.015 Bujarski, S., Hutchison, K. E., Prause, N., & Ray, L. A. (2015). Functional significance of subjective response to alcohol across levels of alcohol exposure. Addiction Biology, 22(1), 235-245. doi:10.1111/adb.12293 Smith, K. S., Tindell, A. J., Aldridge, J. W., & Berridge, K. C. (2009). Ventral pallidum roles in reward and motivation. Behavioural Brain Research, 196(2), 155-167. doi:10.1016/j.bbr.2008.09.038 Gr�sser, S. M., Wrase, J., Klein, S., Hermann, D., Smolka, M. N., Ruf, M., … Heinz, A. (2004). Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology, 175(3), 296-302. doi:10.1007/s00213-004-1828-4 Everitt, B. J., & Robbins, T. W. (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature Neuroscience, 8(11), 1481-1489. doi:10.1038/nn1579 Kranzler, H. R., Stephenson, J. J., Montejano, L., Wang, S., & Gastfriend, D. R. (2008). Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization. Addiction, 103(11), 1801-1808. doi:10.1111/j.1360-0443.2008.02345.x Swift, R., Oslin, D. W., Alexander, M., & Forman, R. (2011). Adherence Monitoring in Naltrexone Pharmacotherapy Trials: A Systematic Review*. Journal of Studies on Alcohol and Drugs, 72(6), 1012-1018. doi:10.15288/jsad.2011.72.1012 Magill, M., & Ray, L. A. (2009). Cognitive-Behavioral Treatment With Adult Alcohol and Illicit Drug Users: A Meta-Analysis of Randomized Controlled Trials. Journal of Studies on Alcohol and Drugs, 70(4), 516-527. doi:10.15288/jsad.2009.70.516 Bernardi, R. E., Zohsel, K., Hirth, N., Treutlein, J., Heilig, M., Laucht, M., … Sommer, W. H. (2016). A gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology. Translational Psychiatry, 6(7), e861-e861. doi:10.1038/tp.2016.132

Incubation of neural alcohol cue reactivity after withdrawal and its blockade by naltrexone

Abstract